Author： Remick D.
Publisher： Informa Healthcare
ISSN： 1471-177X
Source： Cytokines, Cellular & Molecular Therapy, Vol.7, Iss.1, 2002-03, pp. : 38-39
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
The cellular pharmacology of oxaliplatin resistance
By Mishima M. Samimi G. Kondo A. Lin X. Howell S.B.
European Journal of Cancer, Vol. 38, Iss. 10, 2002-07 ,pp. :
Pharmacology and Pharmacogenetics of Chemotherapeutic Agents
By Dawood Shaheenah Leyland-Jones Brian
Cancer Investigation, Vol. 27, Iss. 5, 2009-06 ,pp. :
Antitumor Pharmacology - Quo Vadis ?
Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 4, Iss. 5, 2004-09 ,pp. :
The paradox of pro-inflammatory cytokines in cancer
Cancer and Metastasis Reviews, Vol. 25, Iss. 3, 2006-09 ,pp. :